Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:19 pm Unchanged |
2024-09-30 | 13G | Protagenic Therapeutics, Inc. PTIX |
Armistice Capital, LLC | 17,143 5.100% |
0 (Unchanged) |
Filing History |
| 2024-11-14 5:18 pm Sale |
2024-09-30 | 13G | Rekor Systems, Inc. REKR |
Armistice Capital, LLC | 2,850,000 3.120% |
-4,200,000 (-59.57%) |
Filing History |
| 2024-11-14 5:18 pm Purchase |
2024-09-30 | 13G | Nevro Corp. NVRO |
Armistice Capital, LLC | 3,728,000 10.000% |
552,000 (+17.38%) |
Filing History |
| 2024-11-14 5:18 pm Purchase |
2024-09-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Armistice Capital, LLC | 1,536,000 8.730% |
1,536,000 (New Position) |
Filing History |
| 2024-11-14 5:17 pm Purchase |
2024-09-30 | 13G | Rockwell Medical, Inc. RMTI |
Armistice Capital, LLC | 3,581,525 11.100% |
200,991 (+5.95%) |
Filing History |
| 2024-11-14 5:17 pm Purchase |
2024-09-30 | 13G | NanoVibronix, Inc. NAOV |
Armistice Capital, LLC | 306,619 9.990% |
79,610 (+35.07%) |
Filing History |
| 2024-11-14 5:16 pm Purchase |
2024-09-30 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Armistice Capital, LLC | 3,357,953 9.990% |
1,593,953 (+90.36%) |
Filing History |
| 2024-11-14 5:16 pm Purchase |
2024-09-30 | 13G | My Size, Inc. MYSZ |
Armistice Capital, LLC | 141,523 9.990% |
141,523 (New Position) |
Filing History |
| 2024-11-14 5:16 pm Purchase |
2023-12-31 | 13G | Sadot Group Inc. SDOT |
Armistice Capital, LLC | 607,422 9.990% |
607,422 (New Position) |
Filing History |
| 2024-11-14 5:16 pm Purchase |
2024-09-30 | 13G | Presidio Property Trust, Inc. SQFT |
Armistice Capital, LLC | 161,283 9.990% |
15,556 (+10.68%) |
Filing History |
| 2024-11-14 5:15 pm Purchase |
2024-09-30 | 13G | Mural Oncology plc MURA |
Armistice Capital, LLC | 1,700,000 9.980% |
42,000 (+2.53%) |
Filing History |
| 2024-11-14 5:15 pm Purchase |
2024-09-30 | 13G | Staffing 360 Solutions, Inc. STAF |
Armistice Capital, LLC | 105,610 9.990% |
105,610 (New Position) |
Filing History |
| 2024-11-14 5:14 pm Unchanged |
2024-09-30 | 13G | Momentus Inc. MNTS |
Armistice Capital, LLC | 202,476 9.990% |
0 (Unchanged) |
Filing History |
| 2024-11-14 5:14 pm Purchase |
2024-09-30 | 13G | Supernus Pharmaceuticals, Inc. SUPN |
Armistice Capital, LLC | 5,096,000 9.250% |
446,000 (+9.59%) |
Filing History |
| 2024-11-14 5:14 pm Purchase |
2024-09-30 | 13G | Momentus Inc. MNTS |
Armistice Capital, LLC | 202,476 9.990% |
167,334 (+476.15%) |
Filing History |
| 2024-11-14 5:13 pm Purchase |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
Armistice Capital, LLC | 7,648,000 10.000% |
264,000 (+3.58%) |
Filing History |
| 2024-11-14 5:13 pm Purchase |
2024-09-30 | 13G | MacroGenics, Inc. MGNX |
Armistice Capital, LLC | 6,258,000 9.980% |
1,686,000 (+36.88%) |
Filing History |
| 2024-11-14 5:12 pm Purchase |
2024-09-30 | 13G | Catheter Precision, Inc. VTAK |
Armistice Capital, LLC | 105,743 9.990% |
105,743 (New Position) |
Filing History |
| 2024-11-14 5:12 pm Purchase |
2024-09-30 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 5,200,000 9.540% |
964,000 (+22.76%) |
Filing History |
| 2024-11-14 5:12 pm Purchase |
2024-09-30 | 13G | Moleculin Biotech, Inc. MBRX |
Armistice Capital, LLC | 300,988 9.990% |
300,988 (New Position) |
Filing History |